97581-31-2 Usage
Description
7-Methoxy-6-Methylquinoline is a chemical compound with the molecular formula C11H9NO, belonging to the quinoline family of heterocyclic aromatic compounds. It is a yellow crystalline solid at room temperature, soluble in organic solvents like ethanol and ether, and serves as a building block in organic synthesis for pharmaceuticals and agrochemicals. Additionally, it has been studied for its potential anti-inflammatory and anti-cancer properties.
Uses
Used in Pharmaceutical Industry:
7-Methoxy-6-Methylquinoline is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
7-Methoxy-6-Methylquinoline is used as a building block in the creation of agrochemicals, playing a role in the development of pesticides and other agricultural products to improve crop protection and yield.
Used in Scientific Research:
7-Methoxy-6-Methylquinoline is utilized as a subject of study in scientific research to explore its potential anti-inflammatory and anti-cancer properties, with the aim of discovering new treatments and therapies for various diseases.
Used in Organic Synthesis:
7-Methoxy-6-Methylquinoline is used as a versatile building block in organic synthesis, enabling the production of a wide range of chemical compounds for various applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 97581-31-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,5,8 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 97581-31:
(7*9)+(6*7)+(5*5)+(4*8)+(3*1)+(2*3)+(1*1)=172
172 % 10 = 2
So 97581-31-2 is a valid CAS Registry Number.
97581-31-2Relevant articles and documents
MODULATORS OF CXCR7
-
Page/Page column 70, (2010/06/11)
Compounds having formula (I) or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present inven
